Search Login Register

roscovitine Summary

Description: inhibits cdk2; structure in first source

Also Known As: 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine; CYC 202; CYC-202; CYC202; R-roscovitine Show All >>

Networked: 270 relevant articles (15 outcomes, 68 trials/studies) for this Bio-Agent

Key Diseases for which roscovitine is Relevant

  1. Neoplasms (Cancer) : 4 outcomes 26 studies in 94 results
  2. Glomerulonephritis : 2 outcomes 4 studies in 9 results
  3. Nephritis : 2 outcomes 1 study in 4 results
  4. Breast Neoplasms (Breast Cancer) : 1 outcome 5 studies in 32 results
  5. Multiple Myeloma : 1 outcome 2 studies in 5 results
Show All >>

Drugs Related to roscovitine

  1. Phosphotransferases (Kinase)
  2. Cyclins
  3. Cyclin-Dependent Kinases (cdk Proteins)
  4. flavopiridol
  5. Doxorubicin (Adriamycin)
  6. DNA (Deoxyribonucleic Acid)
  7. Bromodeoxyuridine (BrdU)
  8. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
  9. Hormones
  10. Mitogen-Activated Protein Kinase 3
Show All >>

Therapies Related to roscovitine

  1. Heterologous Transplantation (Xenotransplantation)
  2. Injections
  3. Drug Therapy (Chemotherapy)
  4. Stents
  5. Nephrectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.